Home/SEC 13D/G/LYELSEC 13D/GLYEL - Lyell Immunopharma, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified$LYEL$13.95▼ -52.14% YTDHealthcareAug 14, 2026 · ThinkSabio BlogSEC Filing Update: #LYEL Lyell Immunopharma, Inc. : $13.95 Sector: Healthcare | YTD: 🔽 -52.14% The SEC disclosed Today (14-AUG-2026) that FORESITE CAPITAL FUND IV, L.P. has DECREASED #LYEL Shares by -100.00% 🔴 * Previous Holdings: 800.34K Shares * Current Holdings: 0.00 Shares * Decrease -800.34K * Decreased (%)-100.00% * Ownership: 0.0% https://www.thinksabio.com/reports/isr/LYEL Institutional ownership in #LYEL has been steadily rising over the past 7 quarters in Shares: Q3 2024: 6.42M Q4 2024: 7.51M Q1 2025: 8.01M Q2 2025: 9.26M Q3 2025: 10.29M Q4 2025: 12.10M Q1 2026: 12.67M Share this post🔗Copy LinkMore filings for $LYEL$LYEL SEC Filing Update (18-JUN-2026) | ThinkSabio - Stocks SimplifiedJun 18, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G